Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration
Open Access
- 17 April 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 969-974
- https://doi.org/10.1016/j.omtm.2020.04.012
Abstract
No abstract availableFunding Information
- Biogen
- University of Pennsylvania
This publication has 19 references indexed in Scilit:
- A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna MagnaMolecular Therapy, 2019
- Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiencyBrain, 2019
- Standardized Method for Intra-Cisterna Magna Delivery Under Fluoroscopic Guidance in Nonhuman PrimatesHuman Gene Therapy Methods, 2018
- Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus MacaquesMolecular Therapy - Methods & Clinical Development, 2018
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMNHuman Gene Therapy, 2018
- Single-Dose Gene-Replacement Therapy for Spinal Muscular AtrophyThe New England Journal of Medicine, 2017
- Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman PrimatesMolecular Therapy, 2015
- Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magnaMolecular Therapy - Methods & Clinical Development, 2014
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapyJCI Insight, 2013
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's DiseaseHuman Gene Therapy, 2012